CL2012000271A1 - Compuestos derivados de metilpirrolo[3,2-d]pirimidincarboxamida, inhibidores de pde5; composición farmacéutica que los comprende; y uso en el tratamiento en enfermedades de las vías respiratorias, hipertensión portal, nefritis, cirrosis hepática, entre otras. - Google Patents
Compuestos derivados de metilpirrolo[3,2-d]pirimidincarboxamida, inhibidores de pde5; composición farmacéutica que los comprende; y uso en el tratamiento en enfermedades de las vías respiratorias, hipertensión portal, nefritis, cirrosis hepática, entre otras.Info
- Publication number
- CL2012000271A1 CL2012000271A1 CL2012000271A CL2012000271A CL2012000271A1 CL 2012000271 A1 CL2012000271 A1 CL 2012000271A1 CL 2012000271 A CL2012000271 A CL 2012000271A CL 2012000271 A CL2012000271 A CL 2012000271A CL 2012000271 A1 CL2012000271 A1 CL 2012000271A1
- Authority
- CL
- Chile
- Prior art keywords
- treatment
- respiratory tract
- pyrimidinecarboxamide
- methylpyrrolo
- nephritis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
LA PRESENTE INVENCIÓN DESCRIBE COMPUESTOS DE FÓRMULA (1) LAS SALES FARMACÉUTICAS DE LOS MISMOS, Y LOS ESTEREOISÓMEROS DE LOS COMPUESTOS Y LAS SALES FARMACÉUTICAS DE LOS MISMOS EN DONDE RL, R2, R3, R21, R22, R23, R24 Y Y TIENEN LOS SIGNIFICADOS COMO SE INDICA EN LA MEMORIA DESCRIPTIVA Y PLIEGO DE REIVINDICACIONES; ADICIONALMENTE<br /> SE DESCRIBEN LAS COMPOSICIONES FARMACÉUTICAS QUE COMPRENDEN A DICHOS COMPUESTOS; Y AL USO DE LOS MISMOS EN LA PREPARACIÓN DE UN MEDICAMENTO ÚTIL EN EL TRATAMIENTO O PROFILAXIS DE UNA ENFERMEDAD AGUDA O CRÓNICA DE LAS VÍAS RESPIRATORIAS, ENTRE ELLAS HIPERTENSIÓN ARTERIAL PULMONAR, Y EL TRATAMIENTO O PROFILAXIS DE ENFERMEDAD ARTERIAL PERIFÉRICA, DÍABETES MELLITUS, SÍNDROME DE RAYNAUD, VEJIGA HIPERACTIVA, SÍNTOMAS DEL TRACTO URINARIO INFERIOR (LUTS), HIPERTENSION PORTAL, NEFRITIS, ENTRE OTRAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09168685 | 2009-08-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2012000271A1 true CL2012000271A1 (es) | 2012-08-31 |
Family
ID=41698276
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2012000271A CL2012000271A1 (es) | 2009-08-26 | 2012-02-01 | Compuestos derivados de metilpirrolo[3,2-d]pirimidincarboxamida, inhibidores de pde5; composición farmacéutica que los comprende; y uso en el tratamiento en enfermedades de las vías respiratorias, hipertensión portal, nefritis, cirrosis hepática, entre otras. |
Country Status (26)
Country | Link |
---|---|
US (2) | US8927557B2 (es) |
EP (1) | EP2470536B1 (es) |
JP (1) | JP5791606B2 (es) |
KR (1) | KR101762884B1 (es) |
CN (1) | CN102574861B (es) |
AR (1) | AR077898A1 (es) |
AU (1) | AU2010288550B2 (es) |
BR (1) | BR112012003616A8 (es) |
CA (1) | CA2771938A1 (es) |
CL (1) | CL2012000271A1 (es) |
CO (1) | CO6491110A2 (es) |
EA (1) | EA021103B1 (es) |
EC (1) | ECSP12011678A (es) |
ES (1) | ES2529563T3 (es) |
HK (1) | HK1169411A1 (es) |
IL (1) | IL218126A (es) |
MX (1) | MX2012002432A (es) |
MY (1) | MY159031A (es) |
NZ (1) | NZ598777A (es) |
PE (1) | PE20121133A1 (es) |
SG (1) | SG178481A1 (es) |
TN (1) | TN2012000034A1 (es) |
TW (1) | TWI471327B (es) |
UA (1) | UA106628C2 (es) |
WO (1) | WO2011023693A1 (es) |
ZA (1) | ZA201200616B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102010021637A1 (de) | 2010-05-26 | 2011-12-01 | Bayer Schering Pharma Aktiengesellschaft | Substituierte 5-Fluor-1H-Pyrazolopyridine und ihre Verwendung |
AR086915A1 (es) * | 2011-06-17 | 2014-01-29 | Nycomed Gmbh | Derivados de ftalazinona-pirrolopirimidinacarboxamida y composiciones farmaceuticas que los contiene |
AU2014220801A1 (en) | 2013-02-21 | 2015-09-10 | Adverio Pharma Gmbh | Forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate |
JP2020097527A (ja) * | 2017-03-31 | 2020-06-25 | 武田薬品工業株式会社 | 複素環化合物 |
CN107286160A (zh) * | 2017-06-05 | 2017-10-24 | 毛佳婧 | 一种抗肝炎药物的哌啶并吡啶并吡唑‑锌配合物的制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2754260B1 (fr) | 1996-10-04 | 1998-10-30 | Adir | Nouveaux derives substitues de biphenyle ou de phenylpyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6187777B1 (en) * | 1998-02-06 | 2001-02-13 | Amgen Inc. | Compounds and methods which modulate feeding behavior and related diseases |
ATE273980T1 (de) * | 2000-06-07 | 2004-09-15 | Almirall Prodesfarma Sa | 6-phenylpyrrolopyrimidindion derivate |
WO2002064598A1 (en) | 2001-02-14 | 2002-08-22 | Warner-Lambert Company Llc | Thieno'2,3-d pyrimidindione derivatives as matrix metalloproteinase inhibitors |
CN100374441C (zh) | 2003-06-06 | 2008-03-12 | 天津倍方科技发展有限公司 | 二氢吡咯[2,3-d]嘧啶-4-酮衍生物,其制备方法及其制药用途 |
US20050124623A1 (en) | 2003-11-26 | 2005-06-09 | Bender John A. | Diazaindole-dicarbonyl-piperazinyl antiviral agents |
US7713979B2 (en) | 2004-10-29 | 2010-05-11 | Eli Lilly And Company | Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
CA2599368A1 (en) * | 2005-03-09 | 2006-09-14 | Nycomed Gmbh | Amido-substituted 6-phenylphenanthridines |
EP2057165B1 (en) | 2006-09-07 | 2011-03-16 | Industrial Research Limited | Acyclic amine inhibitors of nucleoside phosphorylases and hydrolases |
JP4837701B2 (ja) * | 2007-04-20 | 2011-12-14 | 田辺三菱製薬株式会社 | 医薬組成物 |
AR070454A1 (es) * | 2008-02-27 | 2010-04-07 | Nycomed Gmbh | Pirrolopirimidincarboxamidas y composiciones farmaceuticas que las comprenden |
-
2010
- 2010-08-23 AR ARP100103064A patent/AR077898A1/es unknown
- 2010-08-24 UA UAA201203246A patent/UA106628C2/uk unknown
- 2010-08-24 SG SG2012011219A patent/SG178481A1/en unknown
- 2010-08-24 EP EP10744949.8A patent/EP2470536B1/en active Active
- 2010-08-24 KR KR1020127006983A patent/KR101762884B1/ko active IP Right Grant
- 2010-08-24 NZ NZ598777A patent/NZ598777A/xx not_active IP Right Cessation
- 2010-08-24 BR BR112012003616A patent/BR112012003616A8/pt not_active Application Discontinuation
- 2010-08-24 CN CN201080046838.4A patent/CN102574861B/zh not_active Expired - Fee Related
- 2010-08-24 CA CA2771938A patent/CA2771938A1/en not_active Abandoned
- 2010-08-24 PE PE2012000214A patent/PE20121133A1/es not_active Application Discontinuation
- 2010-08-24 US US13/390,940 patent/US8927557B2/en not_active Expired - Fee Related
- 2010-08-24 EA EA201200322A patent/EA021103B1/ru not_active IP Right Cessation
- 2010-08-24 ES ES10744949.8T patent/ES2529563T3/es active Active
- 2010-08-24 JP JP2012526038A patent/JP5791606B2/ja not_active Expired - Fee Related
- 2010-08-24 WO PCT/EP2010/062329 patent/WO2011023693A1/en active Application Filing
- 2010-08-24 MY MYPI2012000701A patent/MY159031A/en unknown
- 2010-08-24 MX MX2012002432A patent/MX2012002432A/es active IP Right Grant
- 2010-08-24 AU AU2010288550A patent/AU2010288550B2/en not_active Ceased
- 2010-08-25 TW TW99128511A patent/TWI471327B/zh not_active IP Right Cessation
-
2012
- 2012-01-24 TN TNP2012000034A patent/TN2012000034A1/en unknown
- 2012-01-25 ZA ZA2012/00616A patent/ZA201200616B/en unknown
- 2012-02-01 CL CL2012000271A patent/CL2012000271A1/es unknown
- 2012-02-02 CO CO12018550A patent/CO6491110A2/es unknown
- 2012-02-15 IL IL218126A patent/IL218126A/en not_active IP Right Cessation
- 2012-02-15 EC ECSP12011678 patent/ECSP12011678A/es unknown
- 2012-10-16 HK HK12110218.1A patent/HK1169411A1/zh not_active IP Right Cessation
-
2014
- 2014-11-19 US US14/547,938 patent/US9376442B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY30312A1 (es) | Derivados de n-(2-tiazolil)-amida como inhibidores de gsk-3 | |
AR112074A2 (es) | Derivados de 2-carboxamida-cicloamino-urea como inhibidores de pi-3 | |
ECSP10010556A (es) | Piridinas y pirazinas como inhibidores de pi3k | |
BR112015018751A2 (pt) | derivados de piridazinona macrocíclicos | |
ECSP11010948A (es) | Inhibidores de las enzimas de proteína cinasa activadas por | |
CO6501168A2 (es) | Inhibidor de la map cinasa p38 | |
GT200600134A (es) | Compuestos novedosos de derivados de aminosulfonilo | |
CL2012000271A1 (es) | Compuestos derivados de metilpirrolo[3,2-d]pirimidincarboxamida, inhibidores de pde5; composición farmacéutica que los comprende; y uso en el tratamiento en enfermedades de las vías respiratorias, hipertensión portal, nefritis, cirrosis hepática, entre otras. | |
DOP2011000204A (es) | Inhibidores de proteina cinasa | |
UY28756A1 (es) | Compuestos | |
CU20110129A7 (es) | Piridiloxi-indoles inhibidores del vegf-r2 y uso de los mismos para el tratamiento de enfermedades | |
CO6690816A2 (es) | Derivados de quinazolin-4(3h)-ona utilizados como inhibidores de pi3 cinasa | |
ECSP088974A (es) | Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3) | |
BR122013025375B8 (pt) | compostos orgânicos, seus métodos de preparo e uso, bem como composições farmacêuticas | |
MX2009002239A (es) | Derivados de 5-(2-furil)-1,3-tiazol util como inhibidores de fosfatidilinositol 3-cinasa. | |
CL2011001082A1 (es) | Compuestos derivados de amino-tetrahidropiranos sustituidos con heterociclos, composicion farmaceutica; y uso en el tratamiento de una afeccion seleccionada de resistencia a la insulina, hiperglicemia y diabetes de tipo 2. | |
CL2011002787A1 (es) | Compuestos derivados de 1-cianoetilheterociclilcarboxamida sustituidos, inhibidores de dipeptidilpeptidasa i (dppi) o catepsina c; composicion farmaceutica; combinacion faramceutica; y su uso en el tratamiento del asma, la enfermedad obstructiva cronica o la rinitis alergica. | |
WO2008030412A3 (en) | Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease | |
UY28755A1 (es) | Compuestos | |
EA200801996A1 (ru) | 2-замещенные производные 4-бензилфталазинонов в качестве гистаминовых h1- и h3-антагонистов | |
ECSP109882A (es) | Derivados de 1-cianociclopropilo como inhibidores de la catepsina k | |
UY31431A1 (es) | Inhibidor de la proteina activadora de la 5-lipoxigenasa (flap) | |
CR11208A (es) | Derivados de pirimidina utiles para el tratamiento de condiciones inflamatorias o alergicas | |
BR112012015967A2 (pt) | uso de compostos de fórmula geral (i) e composição farmacêutica | |
EA200870302A1 (ru) | 1,3-диоксанкарбоновые кислоты |